Updated time: 2021-02-26 16:55:50
28A-1050418B
2021-02-26
US 10562976 B2
Disclosed herein is an immunoconjugate comprising an antibody, a functional motif, and a linker connecting the functional motif to the antibody. According to embodiments of the present disclosure, the antibody may recognize tumor-associated antigens, and serves as a targeting module for delivering the functional motif connected therewith to the tumor cells thereby inhibiting tumor growth or detecting the distribution of tumor cells. Also disclosed herein are methods of treating cancers and methods of diagnosing cancers by use of the present immunoconjugate.
- To screen the efficiency of immunoconjugate candidates-induced endocytosis.
- Cancer therapy.
- Immunoliposomes.
- Diagnostic antibodies.

Fig1. Bio-distributions of the anti-HER2 IgG1s in N87 xenograft models.

Fig2. Excised tumor tissues from control and anti-HER2 IgG1-vc-MMAE-treated mice.
An-Suei Yang, Wei-Ying Kuo, Hung-Ju Hsu, Hong-Sen Chen, Yu-Chi Chou, Yueh-Liang Tsou, Hung-Pin Peng, Jhih-Wei Jian, Chung-Ming Yu, Yi-Kai Chiu, Ing-Chein Chen, Chao-ping Tung, Michael Hsiao, Hwei-Jiung Wang
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

IMMUNOCONJUGATE AND USES THEREOF